Clinical Trials Browser

Withdrawn × Morphine × Clear all

NCT05325164 2022-12-05

METHADOPT

Phase 3 Withdrawn

Cancer Pain, Adenocarcinoma, Neoplasms

NCT00306020 2012-07-04

Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain

Phase NA Withdrawn

Neoplasms, Skin Ulcer, Ulcer, Wounds and Injuries, Chronic Pain